WASATCH ADVISORS INC 13D and 13G filings for Exagen Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 5:10 pm Sale |
2024-02-09 | 13G | Exagen Inc. XGN |
WASATCH ADVISORS INC | 850,308 4.900% |
-150,253 (-15.02%) |
Filing |
| 2023-02-09 5:03 pm Sale |
2023-02-09 | 13G | Exagen Inc. XGN |
WASATCH ADVISORS INC | 1,000,561 6.100% |
-105,199 (-9.51%) |
Filing |
| 2022-02-11 2:09 pm Sale |
2022-02-11 | 13G | Exagen Inc. XGN |
WASATCH ADVISORS INC | 1,105,760 6.800% |
-585,747 (-34.63%) |
Filing |
| 2021-04-09 2:00 pm Purchase |
2021-04-09 | 13G | Exagen Inc. XGN |
WASATCH ADVISORS INC | 1,691,507 10.000% |
647,104 (+61.96%) |
Filing |
| 2021-02-11 2:47 pm Purchase |
2021-02-11 | 13G | Exagen Inc. XGN |
WASATCH ADVISORS INC | 1,044,403 8.300% |
1,044,403 (New Position) |
Filing |